CompletedHealthcare8 May 2025

Catheter Precision, Inc. to acquire Cardionomic, Inc.

Verified deal facts, source-backed narrative, and the Exit Mode founder lens for SME readers preparing to sell.

Deal facts

Buyer
Catheter Precision, Inc.
Target
Cardionomic, Inc.
Deal value
USD 1,500,000
Announced
8 May 2025
Status
Completed
Sector
Healthcare
Country
United States
Consideration
shares, loan-note
What we know

More M&A Tools

Explore the Toolkit

Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.

Access now

Deal timeline

1 update
  1. CompletedClosed

    Catheter Precision, Inc. completes acquisition of Cardionomic, Inc.

    Item 1.01. Entry into a Material Definitive Agreement. Acquisition of Assets As previously disclosed, in February 2025, Catheter Precision, Inc. (the “Company”) formed its subsidiary Cardionomix, Inc., a Nevada Corporation (“Cardionomix”), in order to pursue the acquisition of certain assets of Cardionomic, Inc., a Delaware corporation, which has ceased operations. We issued 82% of the common stoc

    Source

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

Similar deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

11 August 2026ClearedHealthcare

Dolby Medical Home Respiratory Care Limited (Vivisol) to acquire Air Liquide Healthcare Limited’s home oxygen services business

Dolby Medical Home Respiratory Care Limited, trading as Vivisol, has agreed to acquire the home oxygen services business of Air Liquide Healthcare Limited in a strategic…

Buyer
Dolby Medical Home Respiratory Care Limited (Vivisol)
Target
Air Liquide Healthcare Limited’s home oxygen services business
Deal value
Not disclosed
Deal type
strategic acquisition

Buyer history

Catheter Precision, Inc.

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive